Through oral 5α-reductase inhibitors, finasteride and dutasteride, have achieved significant improvements in male AGA, they are associated with sexual dysfunction and neuropsychiatric side effects,[3] It is therefore very interesting and important to develop better therapy that can specifically target AR downstream pathways and factors. The gene discussed is AR; the disease is sexual dysfunction.